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Complete androgen insensitivity syndrome is anX-linked recessive androgen receptor disorder characterized by a female phenotype
with an XY karyotype. Individuals affected by this syndrome have normal female external genitalia but agenesis of the Mu¨llerian
duct derivatives, that is, absence of the Fallopian tubes, uterus, cervix, and the proximal part of the vagina, with presence of
endoabdominal, labial, or inguinal testes.The estimated prevalence is between 1 and 5 in 100,000 genetic males. Complete androgen
insensitivity syndrome can be diagnosed as a result of mismatch between the prenatal sex prediction and the phenotype at birth,
can be detected by chance, or remain undetected until investigations for primary amenorrhea. Imaging can be important both to
diagnose the pathology and to localize gonads prior to surgical treatment. In this paper, we present three cases of complete androgen
insensitivity syndrome in adult women of 34, 22, and 38 years old.
1. Case 1
A 34-year-old female was referred by the endocrinologist
of our hospital. Her older sister had been diagnosed with
complete androgen insensitivity syndrome (CAIS) at the age
of 17. She had a female phenotype with normal external
genitalia, normal breast development, and little axillary and
pubic hair. The digital vaginal examination revealed a short,
tight, and blind-ended vagina. An ultrasound (US) exam
performed in another hospital had suggested the presence of
gonads located in the pelvis. A magnetic resonance imaging
(MRI) exam (Figure 1) was performed to plan a laparoscopic
gonadectomy and showed two soft tissue structures sugges-
tive for gonadal tissue located in the right obturator canal
and along the left external iliac artery. A pericentimetric cyst
was found adjacent to each gonad. Apart from the vagina, no
development of Mu¨llerian duct structures was observed.
2. Case 2
A 22-year-old female underwent two episodes of surgery for
inguinal hernia before puberty. She was told that she has no
uterus at the age of 15, but the diagnosis of CAIS was only
recently made at another hospital. She had a male karyotype
but normal female external genitalia and a vagina of normal
size and depth. The patient had a normal height, weight, and
breast development, with very subtle axillary and pubic hair.
She was now referred to our department by the gynecol-
ogist for an ultrasound and MRI exam prior to laparoscopic
gonadectomy. US images (Figure 2) revealed a solid nodule
suggestive of testicular tissue located in both inguinal regions.
The MRI exam (Figure 3) confirmed a testicle in the deep
inguinal ring on both sides and cysts adjacent to them.
The uterus, cervix, and Fallopian tubes were absent, while
the external genitalia and vagina had a normal appearance.
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Figure 1: A 34-year-old female with CAIS syndrome. The axial T2-weighted images ((a) and (b)) show a left testis along the left external
iliac artery and a right testis in the right obturator canal (green arrows) with adjoining cysts (red arrows). Sagittal image (c) shows absence of
Mu¨llerian structures and presence of the lower vagina (yellow arrowheads) (3T magnetic resonance imaging. Axial 4mm fast T2-weighted
images, TR/TE 5030/119ms; sagittal 5mm HASTE-sequence, TR/TE 6500/89).
Figure 2: A 22-year-old girl/female with CAIS. Transabdominal ultrasonography (Hitachi EUB-8500, 14MHz linear array probe) shows the
presence of the right testis in the inguinal canal.
Following gonadectomy, the patient was planned for hor-
monal substitution with estrogens.
3. Case 3
A 38-year-old female was diagnosed with CAIS on the basis
of primary amenorrhea. She presented with amale karyotype
but female phenotype. She had normal external genitalia with
a short vagina, normal height, weight, and breast develop-
ment, no axillary hair, and very little pubic hair. She was
referred to our department to exclude testicular malignancy,
following her informed decision to undergo periodic MRI
(watchful waiting) instead of preventive gonadectomy. The
MRI exam (Figure 4) showed two testes with adjacent cystic
components, each located in the obturator canal. There were
no signs of malignancy. Mu¨llerian derivatives were absent.
A small Bartholin’s cyst was noted on the left side of the
perineum.
4. Discussion
Androgen insensitivity syndrome (AIS) is an X-linked reces-
sive disorder caused by mutations of the androgen receptor
(AR).The responsible gene has been localized at the proximal
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Figure 3: 22-year-old girl/female affected by CAIS. Axial and coronal T2-weighted images ((a) and (b)) revealing the testes (green arrows)
with adjoining cysts on both sides (red arrows). Sagittal image (c) showing absence of the Mu¨llerian structures and the presence of the lower
vagina (yellow arrowheads). (3T Magnetic Resonance Imaging. Axial 4mm fast T2-weighted image, TR/TE 5030/119; sagittal 5mmHASTE-
sequence, TR/TE 6500/89).
long arm of the X chromosome at Xq11-12 [1, 2]. According
to the AR mutation database (http://www.mcgill.ca/andro-
gendb), there are more than 1000 different mutations
reported so far. The syndrome was first described in 1953 by
Morris as testicular feminization, on the basis of his study of
clinical features in 82 patients [3]. The syndrome was later
given the name of androgen insensitivity syndrome.
Depending on the type of AR mutation, the failure of
sexual differentiation can be either complete (CAIS), partial
(PAIS), or mild (MAIS). We described 3 cases of CAIS, in
which dysfunction of the AR is complete. CAIS patients have
a male karyotype with female phenotype and despite testic-
ular production of testosterone (T) and dihydrotestosterone
(DHT), they do not develop either male genitalia or male
secondary sexual characters; furthermore, since the testicular
Sertoli cells produce Mu¨llerian-inhibiting factor (MIF), they
do not developMu¨llerian structures.The testes can be located
in the inguinal canal, sublabial, or intra-abdominal, and they
are very commonly adjoined by small cystic pouches that are
thought to be remnants of the Mu¨llerian or Wolffian ducts
[4]. The prevalence of CAIS is estimated between 1 and 5
in 100,000 genetic males on the basis of a proven molecular
diagnosis [5] (Table 1).
Diagnosis of CAIS is obtained when a male karyotype is
found in individuals with a female phenotype. They typically
almost all have a female gender identity, normal breast devel-
opment, little pubic and axillary hair, primary amenorrhea,
and a blind-ending vagina. Although 77%of patients perceive
their vagina as small and tight, only 35% actually have vaginal
hypoplasia on genital examination [7], sometimes requiring
vaginal dilatation or surgical reconstruction.
CAIS patients are usually taller than women without the
syndrome but shorter than the male population [8]. They
have a low bonemineral density before and/or after gonadec-
tomy [9] that can be corrected by estrogen replacement
therapy and/or calcium and vitamin D supplements. Their
serum testosterone levels are within or above the normal
range for males, and their luteinising hormone (LH) [10] and
serum oestradiol concentrations are higher than in males but
lower than in females without CAIS [11].
Karyotyping should be considered in all female infants
diagnosed with a bilateral inguinal hernia [11, 12] because the
latter is rare in normal female infants and associated with
CAIS in 1-2% of cases during infancy [12, 13].
An intra-abdominal position of the testes is a well-known
cause of malignant degeneration, but since the testes are
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Figure 4: 38-year-old girl/female affected by CAIS. MRI T2-weighted coronal ((a) and (b)) and axial (c) images demonstrating the presence
of the testes (green arrows) and adjoining cysts (red arrows). Sagittal T2 weighted image (d) showing agenesis of theMu¨llerian structures and
presence of the lower third of the vagina (yellow arrowheads). (3T Magnetic Resonance Imaging. Coronal 1mm SPACE-sequence, TR/TE
1500/133; axial 4mm fast-T2-weighted image, TR/TE 4500/119; sagittal 5mm HASTE-sequence, TR/TE 6500/89).
Table 1: Summary table for complete androgen insensitivity syn-
drome (CAIS).
Etiology X-linked recessive androgen receptor dysfunction
Incidence 1/20,400 to 1/99,100
Gender ratio Genetic males
Age
predilection Congenital syndrome
Risk factors Unknown
Treatment
Testicular removal after puberty and estrogen
replacement. Vaginal dilatation or surgical
reconstruction. Psychological support often
needed. Alternative: watchful waiting
Prognosis Good if testes are timely removed
Imaging
findings
Transabdominal US
Absence of Mullerian structures
Presence of testes (usually smaller and slightly
hypoechoic relative to normal testes)
MRI
Axial plane: absence of Mullerian structures,
presence of testes and female external genitalia
Evaluation of incidental testicular malignancy
Sagittal plane: absence of uterus. Evaluation of
presence and length of the lower vagina
Coronal plane: presence of testes and female
external genitalia. Absence of Mullerian structures
normal and not dysgenetic in CAIS, prepubertal tumors are
rare, with an incidence of 0.8% [14], whereas in adults the risk
of gonadal malignancy increases and is estimated to be 14%
(range 0% and 22%) [15].
Although it seems still prudent to perform the laparo-
scopic gonadectomy soon after puberty, the timing of gonad-
ectomy is now becoming controversial in the literature and
manywomen prefer to defer or decline the surgical procedure
[15, 16]. In case of suspectedmalignant transformation before
puberty, the testes can be removed and puberty induced with
estrogen replacement.
CAIS differs from PAIS because of the presence of a
hypospadic micropenis and a bifid scrotum that may contain
the testes.MAIS is not associatedwithmale genital anomalies
but presents as infertility [17].
A very common differential diagnosis of CAIS is
the Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome.
Patients affected by the MRKH syndrome have a female kar-
yotype and normal female external genitalia and ovaries
(located high along the pelvic side wall), but with congenital
aplasia of the uterus and the upper part of the vagina (Table 2)
[6].
Transabdominal US can be used as a first-line examina-
tion for CAIS to assess the absence of Mu¨llerian structures
and to locate the testes. Since US is operator dependent and
can remain inconclusive [18], MRI is the study of choice,
with a reported accuracy up to 100% for the evaluation
of Mu¨llerian duct anomalies [19]. MRI provides detailed
anatomic information due to its superior tissue character-
ization and multiplanar capability. US and MRI have an
equal sensitivity for depicting pelvic gonads, but MRI has
Case Reports in Radiology 5
Table 2: Differential diagnosis for complete androgen insensitivity syndrome (CAIS). Adapted from Gottlieb et al. [6].
Type External genitalia “synonyms” Findings
CAIS Female (“testicularfeminization”)
XY karyotype
Absence of Mullerian structures
Abdominal or inguinal testes
Female external genitalia
Breast development
Blind-ended vagina
Scant or absent pubic and/or axillary hair
Predominantly female
(“incomplete AIS”)
XY karyotype
Absence of Mullerian structures
Breast development
Clitoromegaly and labial fusion
Distinct urethral and vaginal openings or a urogenital sinus
PAIS Ambiguous
XY karyotype
Absence of Mullerian structures
Microphallus (<1 cm) with clitoris-like underdeveloped glans; labia majora-like
bifid scrotum
Descended or undescended testes
Perineoscrotal hypospadias or urogenital sinus
Gynecomastia/development of breast
Predominantly male
XY karyotype
Absence of Mullerian structures
Simple (glandular or penile) or severe (perineal) “isolated” hypospadias with a
normal-sized penis and descended testes or severe hypospadias with micropenis,
bifid scrotum, and either descended or undescended testes
Gynecomastia in puberty
MAIS Male (“undervirilized malesyndrome”)
XY karyotype
Absence of Mullerian structures
Impaired spermatogenesis and/or impaired pubertal virilization
Gynecomastia in puberty
MRKH Female
XX karyotype
Absence of uterus and upper vagina
Presence of female external genitalia and ovaries
Normal breast development
higher sensitivity for the localization of intra-abdominal
gonads [20]. Sagittal and transverse T2-weighted images
(T2WI) and transverse T1-weighted images (T1WI) are used
to reveal the absence of the uterus, to evaluate the vagina,
to assess the presence and location of the testes (which
usually are hypointense onT1WI and slightly hyperintense on
T2WI), and to exclude testicular malignancy [21] (Table 1).
Furthermore, MRI is useful to plan a gonadectomy and, in
addition to tumourmarkers, for awatchful waiting in patients
who refuse surgical removal of the testes.
5. Teaching Point
CAIS is a disorder characterized by a female phenotype
with an XY karyotype. Its diagnosis and management are
typically established in a multidisciplinary team specialised
in disorders of sexual differentiation. US can be used as a
first-line evaluation of the Mu¨llerian structures. However,
MRI is considered as the gold standard because of its higher
accuracy in the evaluation of Mu¨llerian abnormalities. It
plays a key role in the planning of laparoscopic gonadectomy
by revealing the presence and location of the testes and in
watchful waiting in patients who refuse gonadectomy.
Abbreviations
AIS: Androgen insensitivity syndrome
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